| Literature DB >> 23480136 |
Keiran Sm Smalley1, Mercedes Lioni, Kazuhiro Noma, Nikolas K Haass, Meenhard Herlyn.
Abstract
Anticancer drug discovery has long been hampered by the poor predictivity of the preclinical models. There is a growing realization that the tumor microenvironment is a critical determinant of the response of cancer cells to therapeutic agents. The past 5 years have seen a great deal of progress in our understanding of how the three-dimensional microenvironment modulates the signaling behavior of tumor cells. The present review discusses how three-dimensional in vitro cell culture models can benefit cancer drug discovery through an accurate modeling of the tumor microenvironment, leading to more physiologically relevant experimental outcomes.Entities:
Year: 2008 PMID: 23480136 DOI: 10.1517/17460441.3.1.1
Source DB: PubMed Journal: Expert Opin Drug Discov ISSN: 1746-0441 Impact factor: 6.098